Trial Profile
Multicenter, Open-Label, Single-Arm Study to Evaluate a Titration Regimen for Patiromer in Heart Failure Patients With Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Patiromer (Primary) ; Spironolactone
- Indications Heart failure
- Focus Pharmacodynamics
- Sponsors Relypsa
- 05 Jun 2013 New trial record